|Abstract:||Compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, X and n are as defined in the claims and the pharmaceutically acceptable salts thereof are new. These compounds are useful psychotherapeutics and are potent serotonin (5-HT.sub.1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting hypertensives and vasodilators. A process for forming indoles by transition metal catalyzed cyclization of dihalogenated intermediate is also disclosed.|
|Inventor(s):||Macor; John E. (New York, NY)|
|Assignee:||Pfizer Inc. (New York, NY)|
|Filing Date:||Jun 06, 1995|
|Claims:||1. A process for preparing a compound of the formula ##STR77## wherein X is chlorine, bromine, or iodine; A is a first suitable nitrogen protecting group; R.sub.15 is hydrogen, halogen, cyano, --OR.sub.16, --(CH.sub.2).sub.m --(C.dbd.O)NR.sub.17 R.sub.18, --(CH.sub.2).sub.m --SO.sub.2 NR.sub.17 R.sub.18, --(CH.sub.2).sub.m --NR.sub.19 (C.dbd.O)R.sub.20, --(CH.sub.2).sub.m --NR.sub.19 SO.sub.2 R.sub.20, --(CH.sub.2).sub.m --S(O).sub.x R.sub.20, --(CH.sub.2).sub.m --NR.sub.19 (C.dbd.O)NR.sub.17 R.sub.18, --(CH.sub.2).sub.m --NR.sub.19 (C.dbd.O)OR.sub.21, --CH.dbd.CH(CH.sub.2).sub.y R.sub.22, --(CH.sub.2).sub.m --T, and a substituent of the formula ##STR78## B represents a direct bond, C.sub.1 -C.sub.4 alkyl, or C.sub.1 -C.sub.4 alkenyl; D, E, G, and J are each independently oxygen, sulfur, nitrogen or carbon, provided that at least one of D, E, G, and J is nitrogen; R.sub.28, R.sub.29, R.sub.30, and R.sub.31 are each independently hydrogen, C.sub.1 -C.sub.6 alkyl, aryl, C.sub.1 -C.sub.3 alkylaryl, C.sub.1 -C.sub.3 alkylheteroaryl, halogen, cyano, trifluoromethyl, nitro, --OR.sub.32, --NR.sub.32 R.sub.33, --(CH.sub.2).sub.m OR.sub.32, --SR.sub.32, --SO.sub.2 NR.sub.32 R.sub.33, --NR.sub.32 SO.sub.2 R.sub.33, --NR.sub.32 CO.sub.2 R.sub.33, --CONR.sub.32 R.sub.33, or --CO.sub.2 R.sub.32 ; one of R.sub.28 and R.sub.29, R.sub.29 and R.sub.30, or R.sub.30 and R.sub.31 may be taken together to form a five- to seven-membered alkyl ring, a six-membered aryl ring, a five- to seven-membered heteroalkyl ring having 1 heteroatom of N, O, or S, or a five- to six-membered heteroaryl ring having 1 or 2 heteroatoms of N, O, or S; R.sub.32 and R.sub.33 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl, --(CH.sub.2).sub.q R.sub.34, C.sub.1 to C.sub.3 alkylaryl, or aryl; R.sub.32 and R.sub.33 may be taken together to form a C.sub.4 -C.sub.7 alkyl ring; R.sub.34 is cyano, trifluoromethyl, or C.sub.1 -C.sub.4 alkoxy; R.sub.16 is selected from hydrogen, C.sub.1 to C.sub.6 alkyl, and aryl; T is ##STR79## M and Q are each independently oxygen or sulfur; Z is --O--, --S--, --NH, or --CH.sub.2 ; R.sub.35 and R.sub.36 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl, aryl, C.sub.1 to C.sub.3 alkylaryl, or C.sub.1 to C.sub.3 alkylheteroaryl; R.sub.22 is selected from --(C.dbd.O)NR.sub.23 R.sub.24, --SO.sub.2 NR.sub.23 R.sub.24, --NR.sub.25 (C.dbd.O)R.sub.26, --NR.sub.25 SO.sub.2 R.sub.26, --NR.sub.25 (C.dbd.O)NR.sub.23 R.sub.24, --S(O).sub.x R.sub.26 and --NR.sub.7 (C.dbd.O)OR.sub.27 ; R.sub.17, R.sub.18, R.sub.23, and R.sub.24 are independently selected from hydrogen, C.sub.1 to C.sub.6 alkyl, aryl, and C.sub.1 to C.sub.3 alkyl-aryl, or R.sub.17 and R.sub.18 or R.sub.23 and R.sub.24 maybe taken together to form a 4, 5, or 6 membered ring; R.sub.19, R.sub.20, R.sub.21, R.sub.25, R.sub.26, and R.sub.27 are independently selected from hydrogen, C.sub.1 to C.sub.6 alkyl, aryl, and C.sub.1 to C.sub.3 alkyl-aryl; y is 0, 1, or 2; x is 1 or 2; m is 0, 1, 2, or 3; n is 1; q is 1, 2, or 3; a chiral carbon designated by #; and the above aryl groups and the aryl moieties of the above alkylaryl groups are independently selected from phenyl and substituted phenyl, wherein said substituted phenyl may be substituted with one to three groups selected from C.sub.1 to C.sub.4 alkyl, halogen, hydroxy, cyano, carboxamido, nitro, and C.sub.1 to C.sub.4 alkoxy, |
comprising, performing a transition metal catalyzed cyclization on a compound of the formula ##STR80## wherein A and R.sub.15 are as defined above and V is a second suitable nitrogen protecting group.
2. The process of claim 1, wherein X is bromine.
3. The process of claim 1, wherein A is benzyloxycarbonyl.
4. The process of claim 1, wherein V is trifluoroacetyl.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.